tiprankstipranks
Trending News
More News >
Lion Corporation (JP:4912)
:4912
Advertisement

Lion (4912) AI Stock Analysis

Compare
1 Followers

Top Page

JP:4912

Lion

(OTC:4912)

Select Model
Select Model
Select Model
Neutral 69 (OpenAI - 4o)
Rating:69Neutral
Price Target:
¥1,687.00
▲(8.42% Upside)
Lion's overall stock score is primarily influenced by its strong financial performance, despite recent challenges in revenue and cash flow. The technical analysis suggests a bearish trend with potential for a rebound, while the valuation indicates the stock may be overvalued. The absence of earnings call data and corporate events limits additional insights.

Lion (4912) vs. iShares MSCI Japan ETF (EWJ)

Lion Business Overview & Revenue Model

Company DescriptionLion Corporation (4912) is a leading Japanese manufacturer in the personal care, healthcare, and household products sectors. The company is renowned for its development and production of a wide range of products including oral care items like toothpaste and toothbrushes, skincare solutions, and laundry detergents. Lion Corporation is committed to enhancing the quality of life through its innovative and environmentally sustainable products.
How the Company Makes MoneyLion Corporation generates its revenue through the sale of its diverse range of personal care, healthcare, and household products. The company’s key revenue streams include its oral care products, such as toothpaste and mouthwash, which hold a significant market share in Japan. Additionally, its laundry detergents and cleaning products contribute substantially to its income. Lion Corporation also benefits from strategic partnerships and collaborations that enhance its distribution network and expand its market reach, particularly in Asia. The company invests in research and development to innovate and maintain its competitive edge, which is crucial for sustaining its revenue growth.

Lion Earnings Call Summary

Earnings Call Date:Aug 07, 2025
(Q3-2024)
|
% Change Since: |
Next Earnings Date:Nov 06, 2025
Earnings Call Sentiment Neutral
The earnings call highlighted an increase in net sales and profits, driven by effective price revisions and structural reforms. However, challenges such as impairment losses, a decline in domestic sales, and a slowdown in certain overseas markets were also noted. The partnership with Japan Activation Capital is a strategic move to bolster future growth.
Q3-2024 Updates
Positive Updates
Increased Net Sales and Profits
Net sales were JPY 301.1 billion, up 1.7% year-on-year. Core operating income was JPY 18.6 billion, an increase of JPY 6 billion year-on-year.
EBITDA Growth
EBITDA was JPY 32.5 billion, up JPY 6.4 billion year-on-year, with an EBITDA margin increase of 2 percentage points to 10.8%.
Price Revision and Profit Structure Reform
Price revisions led to JPY 2.8 billion in increased profits. The company plans to achieve JPY 4 billion in price revisions by the end of the year.
Overseas Business Performance
Double-digit growth in overseas sales. Thailand grew 1.1%, Malaysia 8.2%, China 9.2%, and South Korea 5.2% in local currency terms.
Partnership with Japan Activation Capital
Announced a partnership with Japan Activation Capital to support management policy strategy and enhance execution speed.
Negative Updates
Impairment Loss on Domestic Facilities
Impairment loss of approximately JPY 6.2 billion due to streamlining of domestic home care production facilities.
Challenges in Fabric Care
Fabric Care business has been in the red due to CapEx and promotion costs, but structural reform is expected to return it to profitability.
Sales Decline in Domestic Consumer Products
Domestic consumer product sales declined by 4.3% due to a reactionary downturn from a previous year's new product launch.
Moderate Growth in Overseas Markets
Growth has slowed down in Southeast and South Asia and Northeast Asia compared to the first half of the year.
Economic Slowdown in China
Chinese economy showing signs of slowing, impacting existing stores, though new distribution networks are expanding.
Company Guidance
In the earnings call for Q3 2024, Lion Corporation reported a 1.7% increase in net sales to JPY 301.1 billion, with a core operating income rise of JPY 6 billion year-on-year, reaching JPY 18.6 billion. The EBITDA was JPY 32.5 billion, up by JPY 6.4 billion, with a margin increase of 2 percentage points to 10.8%. Despite an impairment loss of JPY 6.2 billion due to domestic production facility streamlining, the company maintained its full-year forecast, attributing the resilient performance to price revisions and cost reductions, specifically mentioning a JPY 2.8 billion price revision impact and a total cost reduction of JPY 2.2 billion. The consumer product sales in Japan fell by 4.3%, whereas overseas sales showed sustained double-digit growth. The company plans further asset sales in Q4 to support ongoing structural reforms, aiming for a total shareholder return ratio of 91.9% with a dividend set at JPY 27 per share.

Lion Financial Statement Overview

Summary
Lion exhibits strong profitability and a robust balance sheet with low leverage. However, the recent decline in revenue and free cash flow growth in the TTM period presents potential challenges. The company maintains operational efficiency, but the focus should be on reversing the revenue and cash flow trends to sustain long-term growth.
Income Statement
72
Positive
Lion's income statement shows a stable gross profit margin of around 45% over the years, indicating efficient cost management. However, the TTM data reveals a revenue decline of 10.8%, which is concerning. The net profit margin remains modest at 5.2% in the TTM, reflecting consistent profitability, though slightly lower than previous years. EBIT and EBITDA margins are stable, suggesting operational efficiency. Overall, while profitability is stable, the recent revenue decline is a potential risk.
Balance Sheet
78
Positive
Lion maintains a strong balance sheet with a low debt-to-equity ratio of 0.10 in the TTM, indicating low financial leverage and reduced risk. The return on equity is moderate at 7.5%, showing decent profitability relative to shareholder equity. The equity ratio is healthy, reflecting a strong capital structure. Overall, the balance sheet is robust, with low leverage and solid equity positioning.
Cash Flow
65
Positive
The cash flow statement shows a decline in free cash flow growth by 30.8% in the TTM, which is a concern. The operating cash flow to net income ratio is 0.34, indicating adequate cash generation relative to net income. The free cash flow to net income ratio is 0.52, suggesting reasonable cash flow conversion. While cash flow generation is adequate, the significant decline in free cash flow growth poses a risk.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue413.77B412.94B402.77B389.87B366.23B355.35B
Gross Profit188.99B188.78B180.60B174.61B179.10B179.87B
EBITDA49.88B49.55B43.42B47.31B46.06B56.37B
Net Income20.88B21.20B14.62B21.94B23.76B29.87B
Balance Sheet
Total Assets468.81B497.17B486.36B469.28B428.02B435.50B
Cash, Cash Equivalents and Short-Term Investments80.78B102.24B85.53B101.08B97.25B121.53B
Total Debt29.31B29.74B30.34B32.17B8.37B8.12B
Total Liabilities151.52B181.47B188.23B190.11B163.01B190.65B
Stockholders Equity295.97B293.72B280.32B264.25B251.57B231.72B
Cash Flow
Free Cash Flow13.90B25.60B5.08B18.82B-23.63B13.80B
Operating Cash Flow36.51B43.66B30.07B41.96B19.30B40.73B
Investing Cash Flow-17.23B-7.66B-34.79B-19.54B-34.18B-19.87B
Financing Cash Flow-11.70B-21.20B-11.76B-19.82B-10.22B-9.14B

Lion Technical Analysis

Technical Analysis Sentiment
Negative
Last Price1556.00
Price Trends
50DMA
1557.12
Negative
100DMA
1553.74
Positive
200DMA
1643.33
Negative
Market Momentum
MACD
2.94
Positive
RSI
41.83
Neutral
STOCH
20.20
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4912, the sentiment is Negative. The current price of 1556 is below the 20-day moving average (MA) of 1600.05, below the 50-day MA of 1557.12, and below the 200-day MA of 1643.33, indicating a bearish trend. The MACD of 2.94 indicates Positive momentum. The RSI at 41.83 is Neutral, neither overbought nor oversold. The STOCH value of 20.20 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4912.

Lion Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
585.27B16.9011.92%1.43%15.90%13.60%
72
Outperform
81.15B25.753.51%4.06%-22.80%
70
Outperform
162.41B21.2015.26%4.73%-1.63%1.81%
69
Neutral
¥422.71B20.637.29%1.85%1.29%4.72%
68
Neutral
299.65B46.625.63%3.87%-0.89%-34.14%
60
Neutral
398.55B34.174.72%1.92%-6.64%-13.78%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4912
Lion
1,557.50
-13.50
-0.86%
KBYPF
Kobayashi Pharmaceutical Co
36.00
-2.33
-6.08%
MIOFF
Milbon Co
27.62
0.58
2.14%
PORBF
Pola Orbis Holdings
8.88
-1.28
-12.60%
RPHCF
Rohto Pharmaceutical Co
14.72
-10.07
-40.62%
JP:4928
Noevir Holdings Co., Ltd.
4,730.00
-425.00
-8.24%

Lion Corporate Events

Lion Corporation Reports Stable First Half 2025 Financial Results with Increased Dividends
Aug 7, 2025

Lion Corporation’s financial results for the first half of 2025 show a slight increase in net sales and operating profit, despite a decrease in profit before tax and profit attributable to owners. The company’s core operating income improved significantly, indicating strong regular business performance. The financial position remains stable with a slight increase in total equity, and the company has announced an increase in cash dividends per share, reflecting confidence in future earnings.

The most recent analyst rating on (JP:4912) stock is a Buy with a Yen1750.00 price target. To see the full list of analyst forecasts on Lion stock, see the JP:4912 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 20, 2025